Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
Condition: Locally Advanced and Metastatic Pancreatic Cancer Interventions: Drug: PD-L1/CTLA4 BsAb; Combination Product: GP; Combination Product: FOLFIRINOX Sponsor: Changhai Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Immunotherapy | Pancreas | Pancreatic Cancer | Research | Study